MultiCare Health System

Main Phone Number800-342-9919   Online ChatOnline Chat
Institute for Research & Innovation

Type II Diabetes - Mellitus & High Cardiovascular Risk

Study Number:   10-END-06

Age: 18 yrs or older

Sex: Males and Females

Visits:  Patients will have office visits for a maximum of 4 years (52 weeks treatment followed by 3 annual continuation visits for up to 3 years)

Stipend
: You will be compensated for your time and travel

Principal Investigator(s):  Ronald Graf, MD

Study Coordinator: Shannon Harris, Research Coordinator 253-301-6992

Purpose
: To investigate the efficacy and safety of XXX  treatment in patients with Type 2 Diabetes Mellitus and high cardiovascular risk.